Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 3 de 3
Filtrer
Plus de filtres










Base de données
Gamme d'année
1.
Cureus ; 16(5): e60612, 2024 May.
Article de Anglais | MEDLINE | ID: mdl-38903369

RÉSUMÉ

We discuss a perplexing case of a 51-year-old female with a history of asthma and morbid obesity, presenting with acute bilateral vision loss of unknown etiology. The patient's clinical course was marked by a constellation of symptoms, including blurry vision, eyeball pain, photophobia, headache, nausea, and dizziness, prompting a multidisciplinary approach for diagnostic evaluation. Despite a comprehensive workup and a temporal artery biopsy ruling out large vessel arteritis, the etiology of vision loss remained elusive until myelin oligodendrocyte glycoprotein (MOG) antibody testing returned positive, implicating myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD). High-dose corticosteroid therapy was initiated. However, the patient had worsening visual symptoms and was started on plasmapheresis and subsequent administration of Rituximab to prevent relapses, along with a long-term steroid taper regimen. This case underscores the diagnostic challenge of optic neuritis, particularly in MOGAD. It emphasizes the importance of a thorough evaluation and multidisciplinary collaboration.

2.
Ann Med Surg (Lond) ; 85(6): 2522-2527, 2023 Jun.
Article de Anglais | MEDLINE | ID: mdl-37363445

RÉSUMÉ

Liver impairment has been reported as a common clinical manifestation in patients with Severe Acute Respiratory Syndrome Coronavirus 2 infection, with varying degrees of severity ranging from a mild elevation of liver enzymes to acute liver failure. However, the prevalence and clinical significance of liver injury in Coronavirus Disease 2019 (COVID-19) patients, particularly in low- and middle-income countries such as Nepal, remains poorly understood. To investigate the hepatic injury related to this disease and its clinical significance, the authors conducted a retrospective study that included adult patients with COVID-19 infection in security hospitals of Nepal. Methodology: The authors performed a retrospective chart review on 1007 COVID-19-positive patients who underwent a liver function test during their admission in two COVID-19 dedicated hospitals in Nepal from April 2021 to January 2022. The data were collected and entered into Microsoft Excel before being exported to SPSS version 24 for analysis. Univariate and multivariate logistic regression were used to determine factors associated with liver injury. We reported adjusted odds ratios (aOR) with 95% CI. Results: Of the total, 549 (54.5%) patients had an acute liver injury. Among 549 patients, 68.1% were mild, 27.9% were moderate, and 5.0% were severe. Out of 1007 patients, 1.4% had cholestatic liver injury. Most patients with mild, moderate, and severe liver injury had greater than or equal to 10 C-reactive proteins (CRP). In multivariate logistic regression, sex, and CRP were significantly associated with the presence of liver injury. Males had 1.78 times higher odds of having a liver injury compared to females (aOR:1.78; 95% CI: 1.37-2.30, P-value:<0.001). Similarly, patients who had CRP greater than 10 had higher odds of having liver injury compared to those who had CRP less than 10 (aOR: 1.84; 95% CI: 1.41-2.39; P-value: <0.001). Conclusions: The present study reveals that COVID-19 infection is commonly associated with mild increased liver enzymes. However, the likelihood of developing acute liver injury was found to be higher in patients with an inflammatory state indicated by CRP levels greater than 10. Furthermore, the study highlights the sex-based difference in the prevalence of liver injury, with males demonstrating a higher predisposition.

3.
J Nepal Health Res Counc ; 20(3): 804-807, 2023 Mar 10.
Article de Anglais | MEDLINE | ID: mdl-36974879

RÉSUMÉ

Primary Renal hydatid cyst is a rare entity. We report a case of isolated right renal hydatid cyst in a 13-year-old female who presented with pain in the right lumbar region for 4-5 months and a palpable mass in the right upper quadrant. The radiological features were suggestive of a hydatid cyst in the right kidney with no cyst in the liver, lungs, or left kidney. She was managed medically with oral Albendazole tablets (400 mg twice daily). A total of 6 cycles of Albendazole were given with each cycle lasting for 4 weeks and a drug-free period of 2 weeks in between two consecutive cycles and kept on follow-up for a year. Her condition improved with no recurrence on follow-up after one year. Keywords: Albendazole; echinococcus granulosus; renal hydatid cyst.


Sujet(s)
Kystes , Échinococcose , Tumeurs du rein , Humains , Enfant , Femelle , Adolescent , Albendazole/usage thérapeutique , Népal , Échinococcose/traitement médicamenteux , Rein
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...